Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/1999
10/19/1999US5968548 Use of liposome encapsulated cirprofloxacin as an immunotherapeutic drug
10/19/1999US5968547 Method of providing sustained analgesia with buprenorphine
10/19/1999US5968542 Surgical implants; noncrystallizing carrier
10/19/1999US5968532 Substance p antagonists
10/19/1999US5968519 Antiinflammatory agents or analgesics in mammals
10/19/1999US5968518 Composition and method for treating premenstrual syndrome
10/19/1999US5968251 Production of carotenoid preparations in the form of coldwater-dispersible powders, and the use of the novel carotenoid preparations
10/19/1999CA2154913C Magnetically responsive composition for carrying biologically active substances and methods of production and use
10/19/1999CA2024612C Corticosteroid-containing ointments
10/14/1999WO1999051729A1 Pentaerythritol lipid derivatives
10/14/1999WO1999051717A1 Liposome containing cleaning composition
10/14/1999WO1999051629A2 New compounds for dna-transfection
10/14/1999WO1999051278A1 Inorganic material for radioactive drug delivery
10/14/1999WO1999051273A1 Gelling ophthalmic compositions containing xanthan gum
10/14/1999WO1999051272A1 Injectable igf-formulations containing succinate as buffering agent
10/14/1999WO1999051271A2 Compositions comprising glycol derivatives and alcohols
10/14/1999WO1999051244A1 Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
10/14/1999WO1999051239A1 Formulation of fast-dissolving efavirenz capsules or tablets using super-disintegrants
10/14/1999WO1999051237A1 Oral liquid antidepressant solution
10/14/1999WO1999051230A1 Method for stabilizing pharmaceutical compositions by special use of an antioxidant
10/14/1999WO1999051219A1 Pleuromutilin derivatives for treating nasopharynx infection
10/14/1999WO1999051212A2 Device for the transdermal delivery of diclofenac
10/14/1999WO1999051211A1 Sachet formulations
10/14/1999WO1999051210A1 Modified starch coating
10/14/1999WO1999051209A1 Press coated, pulsatile drug delivery system suitable for oral administration
10/14/1999WO1999051208A1 Controlled release composition
10/14/1999WO1999051207A1 Split tablet and press-through pack
10/14/1999WO1999051206A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999WO1999051205A1 Aerosol composition
10/14/1999WO1999051204A1 Ocular irrigating solution
10/14/1999WO1999051203A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999WO1999051202A2 Quinolone containing liposomes and their use as antibacterial agents
10/14/1999WO1999051201A1 Sustained release formulation
10/14/1999WO1999051192A2 Low residue cosmetic composition
10/14/1999WO1999051096A1 Pulmonary and nasal delivery of raloxifene
10/14/1999WO1999039724A9 Treatment of bony defects with osteoblast precursor cells
10/14/1999WO1999037678A3 Antimicrobial peptides
10/14/1999WO1999037275A3 COSMETIC OR PHARMACEUTICAL PREPARATIONS WITH A LESS STICKY FEEL, CONTAINING GLYCERIN ESTERS OF α-HYDROXY CARBOXYLIC ACIDS AND SATURED FATTY ACIDS
10/14/1999WO1999026604A3 Selected c10 perfluorinated hydrocarbons for liquid ventilation and artificial blood
10/14/1999DE19816070A1 Retardtablette hergestellt aus linearen wasserunlöslichen Polysacchariden Release tablet made of linear water-insoluble polysaccharides
10/14/1999DE19816036A1 Production of pharmaceutical preparations with high disintegration rate containing difficultly soluble active ingredient, e.g. carvedilol
10/14/1999DE19814087A1 Feuchtigkeitsaktivierbares therapeutisches System Moisture-activatable therapeutic system
10/14/1999DE19814084A1 D2-Agonist enthaltendes transdermales therapeutisches System zur Behandlung des Parkinson-Syndroms und Verfahren zu seiner Herstellung D2 agonist-containing transdermal therapeutic system for the treatment of Parkinson's disease and process for its preparation
10/14/1999DE19814083A1 Verfahren zur Herstellung von transdermalen therapeutischen Systemen unter Verwendung von basischen Alkalimetallsalzen zur Umwandlung von Wirkstoffsalzen in die freien Basen A process for the production of transdermal therapeutic systems using basic alkali metal salts for the conversion of active substance salts into the free bases
10/14/1999DE19813011A1 Verfahren zur Herstellung von Mikrokapseln A process for the preparation of microcapsules
10/14/1999DE19813010A1 Mikrokapseln mit verzögertem Release Microcapsules with delayed release
10/14/1999DE19807426A1 Verfahren zur Behandlung von Erkrankungen oder Störungen des Innenohrs A method for the treatment of diseases or disorders of the inner ear
10/14/1999CA2327670A1 Pulmonary and nasal delivery of raloxifene
10/14/1999CA2327367A1 New compounds for dna-transfection
10/14/1999CA2327068A1 Maximizing effectiveness of substances used to improve health and well being
10/14/1999CA2326977A1 Inorganic material for radioactive drug delivery
10/14/1999CA2326732A1 Low residue cosmetic composition
10/14/1999CA2326497A1 Liposome composition and method for administering a quinolone
10/14/1999CA2326183A1 Modified starch coating
10/14/1999CA2326130A1 Cationic lipid formulation delivering nucleic acid to peritoneal tumors
10/14/1999CA2325849A1 Pentaerythritol lipid derivatives
10/14/1999CA2325400A1 Device for the transdermal delivery of diclofenac
10/14/1999CA2321589A1 Liposome containing cleaning composition
10/14/1999CA2228822A1 A polypeptide vector for the delivery of immunogenic epitopes to the immune system using an injection, orally, by a nasal spray, skin patch or transplantable instruments
10/13/1999EP0949203A1 Fine cisplatin powder and process for the production thereof
10/13/1999EP0948965A1 Stable medicinal compositions containing 4,5-epoxymorphinane derivatives
10/13/1999EP0948963A1 Pig appeasing pheromones to decrease stress, anxiety and aggressiveness
10/13/1999EP0948961A2 Effervescent tablet comprising Calcium with an antihistaminic as active agent
10/13/1999EP0948957A2 Use of copolymers of monoethylenically unsaturated carboxylic acids as solubiliser
10/13/1999EP0948638A1 Method for preparing compositions for transferring nucleic acids
10/13/1999EP0948600A2 Nanoscale particles synthesized within an assembled virion
10/13/1999EP0948510A1 Immunostimulatory nucleic acid molecules
10/13/1999EP0948396A1 Microencapsulation process using supercritical fluids
10/13/1999EP0948363A1 Extremely flexible plaster acting dermally or transdermally, and method for producing same
10/13/1999EP0948360A1 Novel lipid compounds and compositions containing same used for the transfer of at least an active substance, in particular a polynucleotide, in a target cell and therapeutic use
10/13/1999EP0948358A1 Stable liquid interferon formulations
10/13/1999EP0948357A1 Use of low molecular weight amino alcohols in ophthalmic compositions
10/13/1999EP0948336A1 Palatable hydroxypropyl methylcellulose ether powder with specified particle size
10/13/1999EP0948332A1 Antiherpetic pharmaceutical compositions containing acyclovir for topical applicators
10/13/1999EP0948322A2 Mucosal administration of substances to mammals
10/13/1999EP0948321A2 Preparation in form of a matrix material-auxiliary agent compound containing optionally an active substance
10/13/1999EP0948320A1 PHARMACEUTICAL COMPOSITIONS FOR SUSTAINED RELEASE OF THE HMG-CoA REDUCTASE INHIBITOR FLUVASTATIN
10/13/1999EP0948319A2 Encapsulated cells producing antibodies
10/13/1999EP0948318A1 Granulates comprising a water soluble compound and cellulose
10/13/1999EP0948317A1 Dispersible macromolecule compositions and methods for their preparation and use
10/13/1999EP0948316A1 Agent for producing a long-lasting saturation effect
10/13/1999EP0948313A2 Use of an extract of gaboon resin in cosmetics and pharmaceutics, in particular for dermatological purposes
10/13/1999EP0775339B1 Current-to-pressure transducer with selectable, adjustable input filter
10/13/1999EP0773827B1 Preparation of cells or dispersed active substances into micro-encapsulated form and thus obtained micro-capsules
10/13/1999EP0658111B1 Methods for enhancing drug delivery with modified saponins
10/13/1999EP0627915B1 Sprayable analgesic composition and method of use
10/13/1999EP0489153B1 Vaccine compositions containing liposomes
10/13/1999CN1231700A Loxoprofen-containing preparation for external use
10/13/1999CN1231609A Antimycotic gel with active substance release
10/13/1999CN1231603A Dosage form providing a sustained and ascending drug release
10/13/1999CN1231601A Oral delayed immediate release formulation and method of preparation therefor
10/13/1999CN1231600A Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium
10/13/1999CN1231593A Fatty acid esters of lactic acid salts as permeation enhancers
10/13/1999CN1231592A Fatty acid esters of glycolic and its salts as permeation enhancers
10/13/1999CN1231582A Use of bilayer forming emulsifiers in nutritional compositions comprising divalent metal salts
10/13/1999CN1231299A Use of copolymers of monoethylenically unsaturated carboxylic acids as solubilizers
10/13/1999CN1231201A Compound donkey-hide gelatin preparation for preventing arrest of bone marrow in chemotherapy and radiotherapy and preparing process thereof
10/13/1999CN1231196A Capsule for promoting male sexual function and preparation process
10/13/1999CN1231195A Capsule for treating prostate diseases and preparation process
10/13/1999CN1231194A Capsule for treating pointed condyloma and preparation process
1 ... 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 ... 2991